Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biosign Technologies Inc BITKF

Biosign Technologies Inc is a Canada based company engaged in the development and selling of cloud-based medical and healthcare software products. Its solutions have applications in clinic management, home care operations, health monitoring and virtual care management. The group derives its revenue from monthly recurring fees, one-time setup charges, training, professional services and the sale... see more

GREY:BITKF - Post Discussion

View:
Post by bluepen1 on Jan 20, 2015 9:46am

News

https://news.money.ca/2015/01/20/biosign-secures-license-sale-with-the-release-of-an-enterprise-version-of-its-clinic-management-software/

Biosign Secures License Sale with the Release of an Enterprise Version of its Clinic Management Software

Canada NewsWire

TORONTO, Jan. 20, 2015 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) (“Biosign” or the “Company”) is pleased to announce that it has signed an initial one year user-based network license agreement with a substantial multi-national corporation, consisting of a large network of physiotherapy, paramedical and rehab clinics and an associated technology services group.  Under this contract Biosign will host the new Enterprise Version of its cloud-based ClinicServer practice management solution. The release of the Enterprise Version will significantly expand the market for the ClinicServer practice management solution. This innovative cloud solution will empower our new customer to manage its complex multi-jurisdictional clinical operations from a centralized and unified technology base. Use of this Enterprise Version will substantially increase their operational efficiencies and also facilitate a new level of electronic payment processing into their expanding network of clinics. The customer  has over 1500 clinics in its group of companies and our solution is currently being rolled-out to the North American division over the next two months.

On December 15th, 2014 ClinicServer began the general roll-out of the Enterprise Version of its cloud-based clinical practice management suite to its existing Canadian client base. As one of the first cloud-based services of its kind in the world, ClinicServer has earned worldwide credibility. ClinicServer’s Enterprise Version offers clinic organizations of all sizes a host of new features designed to increase appointments, improve and standardize documentation, minimize claim rejections and enhance reporting. The new enterprise features make ClinicServer an ideal solution provider to large multi-location clinic organizations. With this Enterprise Version Biosign/ClinicServer can also offer Co-branding and White Label versions to a broad range of other large customers.  

The new ClinicServer Enterprise Version moves the product to a whole new plane and affirms Biosign/ClinicServer as a market-leading cloud-based practice management provider. The Enterprise Version was designed to deal with the unique challenges associated with the management and administration of the day-to-day operations of hundreds or thousands of clinical locations and features brand reporting capabilities, billing and eClaims modules.

Biosign CEO Mike Gross stated: “We are pleased to be working with this multi-national customer and its expanding Healthcare Network. ClinicServer now offers a whole new enterprise-level of cloud-based practice management software that we will continue to deploy in the Canadian market and we are now also uniquely positioned to aggressively expand our international presence as well as our partner relationships.”

About Biosign Technologies Inc (TSXV: BIO) Biosign is a developer of world class healthcare software solutions targeted at the Home Care and Allied Health Care markets. The Company’s various software divisions, including ClinicServer™, EESI Corporate Benefits, Qline Solutions and AioMed GmbH offer industry-leading Home Healthcare and Allied Health clinic management solutions to international companies and service providers worldwide. For more information on Biosign, please visit www.biosign.com.

Comment by nomadtrader on Jan 20, 2015 11:07am
They are quietly making progress and justifying increased expenses. The excerpt below from Page 16 of the Biosign MD&A November 29, 2014 refers to the increased expense of developing the enterprise functionality for the ClinicServer platform. Today's news certainly is a positive indication that the development money spent will be adding to the bottom line in increased revenue. Hopefully ...more  
Comment by whosebid on Jan 28, 2015 10:43am
Well there certainly is no progress in the share price of this dog.  The insiders should be buying up stock and cleaning up the sellers who keep hitting the f*ing bid at a pathetic 1 cent.  They didn't even buy it up when it hit half a cent.  If you believe in your company you should be buying up stock and supporting it.  What are they waiting for?  Dilute the sh*t out ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities